Market Research Logo

Myocardial Infarction Therapeutics - Global Market Outlook (2015-2022)

Myocardial Infarction Therapeutics - Global Market Outlook (2015-2022)

According to Stratistics MRC, the Myocardial Infarction Therapeutics Market is estimated at $XX million in 2015 and is projected to reach $XX million by 2022 growing at a CAGR of XX% from 2015 to 2022. Growing research application, rising demand in increasing incidence of coronary artery disease and changes in lifestyle are some of the key factors driving the market growth. Increasing number of smokers, increasing incidence of obesity and blood pressures, lack of exercise are some of the factors favouring the market growth. However, saturation in R&D would be the major restraint hampering the market.

Analgesics and antiplatelet agents segments are expected to hold more share in this market as these agents are used for initial treatment of an acute myocardial infarction. North America is the fastest growing market in global myocardial infarction therapeutic market due to rise in aging population and prevalence of co-morbidities.

Some of the key players in the market include Anthera Pharmaceuticals, AstraZeneca, Apotex Inc., Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Capricor Inc., Daiichi Sankyo Company Limited, GlaxoSmithKline Plc, Johnson & Johnson, Merck and Co. Inc., Mylan N.V., Novartis N.V., Par Pharmaceutical Companies, Inc., Pfizer Inc., Portola Pharmaceuticals Inc., Sandoz, Sanofi and The Medicines Company.

Products Covered:
Analgesics
Antiplatelet agents
Vasodilators
Thrombolytics and anti-thrombotic agents
Glycoprotein IIb/IIIa inhibitors
Β adrenergic blockers
Angiotensin receptor antagonists
Angiotensin converting enzyme inhibitors
Antithrombotic agents

Distribution Channel Covered:
Hospitals
Hospital Pharmacies
Drug Stores
Online drug stores

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt


What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Myocardial Infarction Therapeutics Market, By Product Type
5.1 Introduction
5.2 Analgesics
5.3 Antiplatelet agents
5.4 Vasodilators
5.5 Thrombolytics and anti-thrombotic agents
5.6 Glycoprotein IIb/IIIa inhibitors
5.7 Β adrenergic blockers
5.8 Angiotensin receptor antagonists
5.9 Angiotensin converting enzyme inhibitors
5.10 Antithrombotic agents
6 Global Myocardial Infarction Therapeutics Market, By Distribution channel
6.1 Introduction
6.2 Hospitals
6.3 Hospital Pharmacies
6.4 Drug Stores
6.5 Online drug stores
7 Global Myocardial Infarction Therapeutics Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Anthera Pharmaceuticals
9.2 AstraZeneca, Apotex Inc.
9.3 Bayer AG
9.4 Boehringer Ingelheim GmbH
9.5 Bristol-Myers Squibb Company
9.6 Capricor Inc.
9.7 Daiichi Sankyo Company Limited
9.8 GlaxoSmithKline Plc
9.9 Johnson & Johnson
9.10 Merck and Co. Inc.
9.11 Mylan N.V.
9.12 Novartis N.V.
9.13 Par Pharmaceutical Companies, Inc.
9.14 Pfizer Inc.
9.15 Portola Pharmaceuticals Inc.
9.16 Sandoz
9.17 Sanofi
9.18 The Medicines Company
List of Tables
Table 1 Global Myocardial Infarction Therapeutics Market Outlook, By Region (2015-2022) ($MN)
Table 2 Global Myocardial Infarction Therapeutics Market Outlook, By Product (2015-2022) ($MN)
Table 3 Global Myocardial Infarction Therapeutics Market Outlook, By Analgesics (2015-2022) ($MN)
Table 4 Global Myocardial Infarction Therapeutics Market Outlook, By Antiplatelet agents (2015-2022) ($MN)
Table 5 Global Myocardial Infarction Therapeutics Market Outlook, By Vasodilators (2015-2022) ($MN)
Table 6 Global Myocardial Infarction Therapeutics Market Outlook, By Thrombolytics and anti-thrombotic agents (2015-2022) ($MN)
Table 7 Global Myocardial Infarction Therapeutics Market Outlook, By Glycoprotein IIb/IIIa inhibitors (2015-2022) ($MN)
Table 8 Global Myocardial Infarction Therapeutics Market Outlook, By Β adrenergic blockers (2015-2022) ($MN)
Table 9 Global Myocardial Infarction Therapeutics Market Outlook, By Angiotensin receptor antagonists (2015-2022) ($MN)
Table 10 Global Myocardial Infarction Therapeutics Market Outlook, By Antithrombotic agents (2015-2022) ($MN)
Table 11 Global Myocardial Infarction Therapeutics Market Outlook, By Distribution channel (2015-2022) ($MN)
Table 12 Global Myocardial Infarction Therapeutics Market Outlook, By Hospitals (2015-2022) ($MN)
Table 13 Global Myocardial Infarction Therapeutics Market Outlook, By Hospital Pharmacies (2015-2022) ($MN)
Table 14 Global Myocardial Infarction Therapeutics Market Outlook, By Drug Stores (2015-2022) ($MN)
Table 15 Global Myocardial Infarction Therapeutics Market Outlook, By Online drug stores (2015-2022) ($MN)
Table 16 North America Myocardial Infarction Therapeutics Market Outlook, By Product (2015-2022) ($MN)
Table 17 North America Myocardial Infarction Therapeutics Market Outlook, By Analgesics (2015-2022) ($MN)
Table 18 North America Myocardial Infarction Therapeutics Market Outlook, By Antiplatelet agents (2015-2022) ($MN)
Table 19 North America Myocardial Infarction Therapeutics Market Outlook, By Vasodilators (2015-2022) ($MN)
Table 20 North America Myocardial Infarction Therapeutics Market Outlook, By Thrombolytics and anti-thrombotic agents (2015-2022) ($MN)
Table 21 North America Myocardial Infarction Therapeutics Market Outlook, By Glycoprotein IIb/IIIa inhibitors (2015-2022) ($MN)
Table 22 North America Myocardial Infarction Therapeutics Market Outlook, By Β adrenergic blockers (2015-2022) ($MN)
Table 23 North America Myocardial Infarction Therapeutics Market Outlook, By Angiotensin receptor antagonists (2015-2022) ($MN)
Table 24 North America Myocardial Infarction Therapeutics Market Outlook, By Antithrombotic agents (2015-2022) ($MN)
Table 25 North America Myocardial Infarction Therapeutics Market Outlook, By Distribution channel (2015-2022) ($MN)
Table 26 North America Myocardial Infarction Therapeutics Market Outlook, By Hospitals (2015-2022) ($MN)
Table 27 North America Myocardial Infarction Therapeutics Market Outlook, By Hospital Pharmacies (2015-2022) ($MN)
Table 28 North America Myocardial Infarction Therapeutics Market Outlook, By Drug Stores (2015-2022) ($MN)
Table 29 North America Myocardial Infarction Therapeutics Market Outlook, By Online drug stores (2015-2022) ($MN)
Table 30 Europe Myocardial Infarction Therapeutics Market Outlook, By Product (2015-2022) ($MN)
Table 31 Europe Myocardial Infarction Therapeutics Market Outlook, By Analgesics (2015-2022) ($MN)
Table 32 Europe Myocardial Infarction Therapeutics Market Outlook, By Antiplatelet agents (2015-2022) ($MN)
Table 33 Europe Myocardial Infarction Therapeutics Market Outlook, By Vasodilators (2015-2022) ($MN)
Table 34 Europe Myocardial Infarction Therapeutics Market Outlook, By Thrombolytics and anti-thrombotic agents (2015-2022) ($MN)
Table 35 Europe Myocardial Infarction Therapeutics Market Outlook, By Glycoprotein IIb/IIIa inhibitors (2015-2022) ($MN)
Table 36 Europe Myocardial Infarction Therapeutics Market Outlook, By Β adrenergic blockers (2015-2022) ($MN)
Table 37 Europe Myocardial Infarction Therapeutics Market Outlook, By Angiotensin receptor antagonists (2015-2022) ($MN)
Table 38 Europe Myocardial Infarction Therapeutics Market Outlook, By Antithrombotic agents (2015-2022) ($MN)
Table 39 Europe Myocardial Infarction Therapeutics Market Outlook, By Distribution channel (2015-2022) ($MN)
Table 40 Europe Myocardial Infarction Therapeutics Market Outlook, By Hospitals (2015-2022) ($MN)
Table 41 Europe Myocardial Infarction Therapeutics Market Outlook, By Hospital Pharmacies (2015-2022) ($MN)
Table 42 Europe Myocardial Infarction Therapeutics Market Outlook, By Drug Stores (2015-2022) ($MN)
Table 43 Europe Myocardial Infarction Therapeutics Market Outlook, By Online drug stores (2015-2022) ($MN)
Table 44 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Product (2015-2022) ($MN)
Table 45 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Analgesics (2015-2022) ($MN)
Table 46 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Antiplatelet agents (2015-2022) ($MN)
Table 47 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Vasodilators (2015-2022) ($MN)
Table 48 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Thrombolytics and anti-thrombotic agents (2015-2022) ($MN)
Table 49 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Glycoprotein IIb/IIIa inhibitors (2015-2022) ($MN)
Table 50 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Β adrenergic blockers (2015-2022) ($MN)
Table 51 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Angiotensin receptor antagonists (2015-2022) ($MN)
Table 52 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Antithrombotic agents (2015-2022) ($MN)
Table 53 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Distribution channel (2015-2022) ($MN)
Table 54 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Hospitals (2015-2022) ($MN)
Table 55 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Hospital Pharmacies (2015-2022) ($MN)
Table 56 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Drug Stores (2015-2022) ($MN)
Table 57 Asia pacific Myocardial Infarction Therapeutics Market Outlook, By Online drug stores (2015-2022) ($MN)
Table 58 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Product (2015-2022) ($MN)
Table 59 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Analgesics (2015-2022) ($MN)
Table 60 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Antiplatelet agents (2015-2022) ($MN)
Table 61 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Vasodilators (2015-2022) ($MN)
Table 62 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Thrombolytics and anti-thrombotic agents (2015-2022) ($MN)
Table 63 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Glycoprotein IIb/IIIa inhibitors (2015-2022) ($MN)
Table 64 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Β adrenergic blockers (2015-2022) ($MN)
Table 65 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Angiotensin receptor antagonists (2015-2022) ($MN)
Table 66 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Antithrombotic agents (2015-2022) ($MN)
Table 67 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Distribution channel (2015-2022) ($MN)
Table 68 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Hospitals (2015-2022) ($MN)
Table 69 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Hospital Pharmacies (2015-2022) ($MN)
Table 70 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Drug Stores (2015-2022) ($MN)
Table 71 Rest of the World Myocardial Infarction Therapeutics Market Outlook, By Online drug stores (2015-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report